Live Breaking News & Updates on Transcend Nhl 001

Stay updated with breaking news from Transcend nhl 001. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Lisocabtagene Maraleucel in R/R MCL: Primary Analysis Results from the MCL Cohort of the Single-Arm, Multicenter, Seamless Design TRANSCEND NHL 001 Study

Alexey Danilov, MD, PhD, reviews data from the TRANSCEND NHL 001 study investigating lisocabtagene maraleucel in patients with relapsed/refractory mantle cell lymphoma. ....

Alexey Danilov , Lisocabtagene Maraleucel , International Conference On Malignant Lymphoma , Primary Analysis Results , Seamless Design , Partnership With , International Conference , Malignant Lymphoma , Transcend Nhl 001 , Relapsed Refractory Mantle Cell Lymphoma , Liso Cel , Relapsed Refractory Mcl , Mantle Cell Lymphoma , Transcend Nhl 001 Study , Rr Mcl , Transcend Nhl 001 Results , Transcend Nhl 001 Data ,